Works in Diabetes, Obesity & Metabolism, 2025, Vol 27, Issue 2
Results: 61
Metformin and risk of adverse pregnancy outcomes among pregnant women with gestational diabetes in the United Kingdom: A population‐based cohort study.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 976, doi. 10.1111/dom.16115
- By:
- Publication type:
- Article
A biweekly DPP‐4 inhibitor cofrogliptin monotherapy in Chinese patients with impaired glucose tolerance: A phase 2, multicenter, randomized, double‐blind, placebo‐controlled, parallel‐group trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 965, doi. 10.1111/dom.16096
- By:
- Publication type:
- Article
Development of a predictive model for gastrointestinal side effects of metformin treatment in Chinese individuals with type 2 diabetes based on four randomised clinical trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 953, doi. 10.1111/dom.16095
- By:
- Publication type:
- Article
Effect of dapagliflozin on renal haemodynamics in hyperfiltering T2D patients.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 944, doi. 10.1111/dom.16094
- By:
- Publication type:
- Article
Psychosocial outcomes in a diverse sample of youth and their families who initiated continuous glucose monitoring within the first year of type 1 diabetes diagnosis.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 933, doi. 10.1111/dom.16093
- By:
- Publication type:
- Article
Intermittent fasting for weight management and metabolic health: An updated comprehensive umbrella review of health outcomes.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 920, doi. 10.1111/dom.16092
- By:
- Publication type:
- Article
Inclisiran versus alirocumab in improving lipid profile parameters: A systematic review and meta‐analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 911, doi. 10.1111/dom.16091
- By:
- Publication type:
- Article
Individual and joint associations of obesity and metabolic health parameters on arterial stiffness: Evidence from the UK Biobank.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 899, doi. 10.1111/dom.16090
- By:
- Publication type:
- Article
The role of the glucagon‐FGF21 axis in improving beta cell function during glucose intolerance and SGLT2 inhibition.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 885, doi. 10.1111/dom.16089
- By:
- Publication type:
- Article
Effect of exercise on plasma insulin levels in individuals with type 1 diabetes: A systematic review and meta‐analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 876, doi. 10.1111/dom.16088
- By:
- Publication type:
- Article
Network Mendelian randomisation analysis deciphers protein pathways linking type 2 diabetes and gastrointestinal disease.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 866, doi. 10.1111/dom.16087
- By:
- Publication type:
- Article
Differential effects of imeglimin and metformin on insulin and incretin secretion—An exploratory randomized controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 856, doi. 10.1111/dom.16086
- By:
- Publication type:
- Article
Postnatal glycaemic outcomes in women with high‐risk gestational diabetes: Identifying key predictors for early intervention.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 845, doi. 10.1111/dom.16085
- By:
- Publication type:
- Article
Three decades of glucose‐lowering therapy in patients at high cardiovascular risk — A real‐world analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 835, doi. 10.1111/dom.16084
- By:
- Publication type:
- Article
Correction to "Real‐world evaluation of the effects of tirzepatide in patients with type 2 diabetes mellitus".
- Published in:
- 2025
- Publication type:
- Correction Notice
Glycaemic response to pasta from three different wheat varieties in individuals with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 1014, doi. 10.1111/dom.16082
- By:
- Publication type:
- Article
Hepatic lipogenesis marked by GCKR‐modulated triglycerides increases serum FGF21 in children/teens with obesity.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 825, doi. 10.1111/dom.16081
- By:
- Publication type:
- Article
Safety, pharmacokinetics and pharmacodynamics of multiple‐dose noiiglutide (SHR20004), a novel GLP‐1 receptor agonist, in Chinese obese subjects without diabetes mellitus.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 816, doi. 10.1111/dom.16080
- By:
- Publication type:
- Article
Effects of sotagliflozin on anaemia in patients with type 2 diabetes and chronic kidney disease stages 3 and 4.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 1010, doi. 10.1111/dom.16079
- By:
- Publication type:
- Article
One or two? Comparison of the cardiorenal effects between combination therapy and monotherapy with SGLT2i or GLP1RA.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 806, doi. 10.1111/dom.16078
- By:
- Publication type:
- Article
Early combination therapy with SGLT2i and GLP‐1 RA or dual GIP/GLP‐1 RA in type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 468, doi. 10.1111/dom.16077
- By:
- Publication type:
- Article
Glucagon‐like peptide 1 (GLP1) receptor agonists and risk for ischemic optic neuropathy: A meta‐analysis of randomised controlled trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 1005, doi. 10.1111/dom.16076
- By:
- Publication type:
- Article
Treatment persistence, adherence and healthcare resource utilisation for iGlarLixi versus basal–bolus insulin or premixed insulin in older adult ethnic minorities with type 2 diabetes: SoliEthnicity study.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 795, doi. 10.1111/dom.16075
- By:
- Publication type:
- Article
Relationship between trajectory of Chinese visceral adiposity index and risk of type 2 diabetes mellitus: Evidence from the China‐PAR project.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 785, doi. 10.1111/dom.16074
- By:
- Publication type:
- Article
Natriuretic peptide levels and predicting risk of developing new diabetes mellitus and metabolic syndrome.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 777, doi. 10.1111/dom.16073
- By:
- Publication type:
- Article
Incidence and risk factors of new‐onset diabetes mellitus: A five‐year follow‐up study in solid organ transplant recipients in Germany.
- Published in:
- 2025
- By:
- Publication type:
- Case Study
Incidence of diabetes mellitus following hospitalisation for COVID‐19 in the United Kingdom: A prospective observational study.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 767, doi. 10.1111/dom.16071
- By:
- Publication type:
- Article
Enhancing postpartum cardiometabolic health for women with previous gestational diabetes: Next steps and unanswered questions for pharmacological and lifestyle strategies.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 447, doi. 10.1111/dom.16070
- By:
- Publication type:
- Article
Integrative transcriptome analysis reveals Serpine2 promotes glomerular mesangial cell proliferation and extracellular matrix accumulation via activating ERK1/2 signalling pathway in diabetic nephropathy.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 750, doi. 10.1111/dom.16069
- By:
- Publication type:
- Article
Development and external validation of an algorithm for self‐identification of risk for microvascular complications in patients with type 1 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 740, doi. 10.1111/dom.16068
- By:
- Publication type:
- Article
Effectiveness and cost‐effectiveness of an app and rewards‐based intervention in type 2 diabetes: A randomised controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 729, doi. 10.1111/dom.16067
- By:
- Publication type:
- Article
Circulating inflammatory proteins are elevated in type 1 and type 2 diabetes and associated to complications.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 719, doi. 10.1111/dom.16066
- By:
- Publication type:
- Article
Similar weight loss with semaglutide regardless of diabetes and cardiometabolic risk parameters in individuals with metabolic dysfunction‐associated steatotic liver disease: Post hoc analysis of three randomised controlled trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 710, doi. 10.1111/dom.16065
- By:
- Publication type:
- Article
Increased gallbladder emptying and reduced GLP‐1 response in pregnancy with and without gestational diabetes mellitus.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 697, doi. 10.1111/dom.16064
- By:
- Publication type:
- Article
Long‐term all‐cause mortality of metabolic‐dysfunction associated steatotic liver disease based on body weight phenotypes following acute myocardial infarction: A retrospective cohort study.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 683, doi. 10.1111/dom.16062
- By:
- Publication type:
- Article
The association between android‐to‐gynoid lean mass ratio and all‐cause and specific‐cause mortality in US adults: A prospective study.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 595, doi. 10.1111/dom.16051
- By:
- Publication type:
- Article
Non‐clinical and first‐in‐human characterization of ECC5004/AZD5004, a novel once‐daily, oral small‐molecule GLP‐1 receptor agonist.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 551, doi. 10.1111/dom.16047
- By:
- Publication type:
- Article
Discontinuation of SGLT2i in people with type 2 diabetes following hospitalisation for heart failure: A cause for concern?
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 997, doi. 10.1111/dom.16061
- By:
- Publication type:
- Article
Targeting the cholinergic anti‐inflammatory pathway for type 2 diabetes prevention: A retrospective cohort study.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 675, doi. 10.1111/dom.16060
- By:
- Publication type:
- Article
The cumulative impact of type 2 diabetes and obstructive sleep apnoea on cardiovascular, liver, diabetes‐related and cancer outcomes.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 663, doi. 10.1111/dom.16059
- By:
- Publication type:
- Article
Comparison of the impact of type 1 and type 2 diabetes on quality of life of families of patients: A UK cross‐sectional study.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 652, doi. 10.1111/dom.16058
- By:
- Publication type:
- Article
De‐intensification of basal‐bolus therapy by replacing prandial insulin with once‐weekly subcutaneous semaglutide in individuals with well‐controlled type 2 diabetes: A single‐centre, open‐label randomised trial (TRANSITION‐T2D)
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 642, doi. 10.1111/dom.16057
- By:
- Publication type:
- Article
The prognostic impact of the Stress Hyperglycemia Ratio on End‐Stage Renal Disease among patients with Diabetic Kidney Disease.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 629, doi. 10.1111/dom.16056
- By:
- Publication type:
- Article
Effect of smoking behaviour and related blood DNA methylation on visceral adipose tissues.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 619, doi. 10.1111/dom.16054
- By:
- Publication type:
- Article
L‐aspartate ameliorates diet‐induced obesity by increasing adipocyte energy expenditure.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 606, doi. 10.1111/dom.16053
- By:
- Publication type:
- Article
Survodutide, a glucagon receptor/glucagon‐like peptide‐1 receptor dual agonist, improves blood pressure in adults with obesity: A post hoc analysis from a randomized, placebo‐controlled, dose‐finding, phase 2 trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 993, doi. 10.1111/dom.16052
- By:
- Publication type:
- Article
Long‐term weight loss and cardiorenal outcomes by baseline BMI in the VERTIS CV trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 583, doi. 10.1111/dom.16050
- By:
- Publication type:
- Article
Benefits of combining SGLT2 inhibitors and pioglitazone on risk of MASH in type 2 diabetes—A real‐world study.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 574, doi. 10.1111/dom.16049
- By:
- Publication type:
- Article
Increased cardiovascular risk in people with LADA in comparison to type 1 diabetes and type 2 diabetes: Findings from the DPV registry in Germany and Austria.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 563, doi. 10.1111/dom.16048
- By:
- Publication type:
- Article
Association between weight reduction achieved with tirzepatide and quality of life in adults with obesity: Results from the SURMOUNT‐1 study.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 539, doi. 10.1111/dom.16046
- By:
- Publication type:
- Article